- Medicover
- Health Screenings
- Genetic health screenings
- The Genetic Predisposition Screening for breast and ovarian cancers
The Genetic Predisposition Screening for breast and ovarian cancers
Warszawa
The price includes all fees
Lowest price from 30 days before discounting PLN 3,325.00How can you benefit from this health screening?
- An assessment of the breast and ovarian cancer risks by means of the state-of-the-art method that complies with the highest standards.
- An analysis of as many as 25 genesincreasing the risk of the disease.
- An individual plan of prevention and early detection of breast and ovarian cancers.
- Reliability and professionalism – unlike other companies on the market, we offer tests from blood samples accompanied by a reliable description of results by a physician. You do not have to collect the sample yourself from the cheek and you are never left alone with the test results.
- Safety – we know that your genetic material represents sensitive medical information and therefore we take all possible measures to properly protect it. We test the specimens in a Warsaw-based laboratory, which allows us to exercise relevant control at every single stage, from collection until disposal after analysis.
- a genetic test a genetic test performed by means of state of the art methods for DNA analysis (NGS – next generation sequencing), guaranteeing high precision and reliability
- an analysis of family history and clinical data as well as test and examination results by a team of specialists
- a gynaecologist consultation
- an individual prevention plan based on the assessment of cancer risk
The screening is particularly recommended if:
- you have a family history of breast or ovarian cancer
- a relative of yours has been diagnosed as the BRCA gene mutations carrier
- you want to detect any potential genetic predispositions in order to undertake early prevention and consciously enjoy your pregnancy
Perform the Screening of Genetic Predispositions to breast and ovarian cancers. Check whether or not you are in the risk group.
The procedure
You can receive your screening during 2 appointments at in Medicover Centre.
- Prior to your appointment in the Medicover Centre, fill in the detailed “Patient’s Survey” concerning cancer incidence in your family, which will be sent to you in the purchase confirmation e mail. Please bring the survey with you to your first appointment in the Medicover Centre.
- During the first appointment, we will collect your blood sample. Next, the blood test results, along with the survey, are assessed by a specialist in genetic diagnostics who sends a relevant opinion with recommendations to the Medicover Centre.
- During the second appointment in the Centre, you will meet your gynaecologistwho will discuss the test results who will discuss the test results and the related recommendations with you. The physician will work with you to establish an individual plan of prevention and early detection of breast and ovarian cancers, ,with particular emphasis on your life plans.
Validity period of the screening: 3 months from the date indicated in the order confirmation.
You can have your health screening at the Medicover Centre Jerozolimskie
Waiting time for the results: up to 7 weeks
Experts estimate that, in Poland, there are approximately 100,000 female and the same number of male carriers of the BRCA1 gene mutation. The occurrence of the mutation does not entail imminent development of breast or ovarian cancer, but considerably increases the related risk during the patient's whole life.
Other factors also influence the occurrence of these cancers. Some of them, for example smoking, increase such a risk while others, such as long-term breastfeeding, reduce it.
Therefore, being aware of your genetic predisposition, you are able to make conscious decisions about the scope of prevention and other measures to reduce the risk of getting cancer.
Others also bought

Hereditary colorectal cancer. An assessment of genetic predispositions to colorectal cancer by means of state-of-the-art methods for DNA analysis (NGS – next-generation sequencing), guaranteeing high precision and reliability. An analysis of as many as 25 genes that increase the risk of the disease. Only 2 appointments in the Centre. Check whether or not you are in the risk group.

An assessment of the breast and ovarian cancer risks by means of the state-of-the-art method that complies with the highest standards.